Arteris, Inc. (AIP) SEC Filings & Earnings Calls
EquiReason read 11 Arteris, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-06 — Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 936.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
6 Aug 202610-QRevenue from customers outside the United States 58.4; Revenue from customers in China 23.2; Net Loss $-22M (+27% y/y)open
Figures in the filing · each found in the filing text
| Revenue from customers outside the United States · H1-2026 | 58.4% | |
| Revenue from customers in China · H1-2026 | 23.2% | |
| Net Loss · H1-2026 | $-22M | +27% y/y |
| Accumulated Deficit · 2026-06-30 | $-194M | |
| Variable Royalty Revenue as % of Total Revenue · H1-2026 | 10.0% |
Risks flagged
China revenue decline from trade restrictions
“We expect our revenue from China to decrease due to the applicable U.S. government trade restrictions.” · word for word
Sustained net losses and accumulated deficit
“We incurred a net loss of $22.0 million and $17.3 million for the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, we had an accumulated deficit of $193.7 million.” · word for word
Customer concentration risk
“A significant amount of our revenue is derived from a limited number of customers.” · word for word
Competition from larger companies with greater resources
“We face significant competition from larger companies and third-party providers that may deploy their resources so they can develop their IP solutions internally.” · word for word
6 Aug 20268-K · 2.02Revenue $24M (+46% y/y); Annual Contract Value plus royalties $100M (+44% y/y); Remaining Performance Obligation $135M (+36% y/y); Guidance: FY26 revenue guidance raised to $95-$98M; ACV+royalties guidance $102-$106Mearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $24M | +46% y/y |
| Annual Contract Value plus royalties · Q2-2026 | $100M | +44% y/y |
| Remaining Performance Obligation · Q2-2026 | $135M | +36% y/y |
| Trailing-twelve-months variable royalties · TTM Q2-2026 | $9M | +65% y/y |
| Operating loss · Q2-2026 | $-14M | |
| Non-GAAP operating loss · Q2-2026 | $-5M | |
| Net loss · Q2-2026 | $-14M | |
| Non-GAAP net loss per share · Q2-2026 | $-0.10 |
Guidance
FY26 revenue guidance raised to $95-$98M; ACV+royalties guidance $102-$106M
Revenue and ACV+royalties guidance raised; strong demand from AI compute; operating losses elevated but expected to narrow.
Risks flagged
Operating losses increasing due to higher investment
“Operating loss $13.9M vs $8.2M prior year; Non-GAAP operating loss $4.6M vs $3.5M.”
12 May 20268-K · 2.02, 5.02Annual Contract Value plus royalties $93M (+39% y/y); Revenue $23M (+39% y/y); Trailing-twelve-months variable royalties $8M (+67% y/y); Guidance: Q2 ACV+royalties guidance $95-99M; FY2026 $102-106Mearningsopen
Figures in the filing · each found in the filing text
| Annual Contract Value plus royalties · Q1-2026 | $93M | +39% y/y |
| Revenue · Q1-2026 | $23M | +39% y/y |
| Trailing-twelve-months variable royalties · TTM-Q1-2026 | $8M | +67% y/y |
| Remaining Performance Obligation · Q1-2026 | $118M | +33% y/y |
Guidance
Q2 ACV+royalties guidance $95-99M; FY2026 $102-106M
Raised ACV+royalties guidance for Q2 and full year FY2026; record backlog and strong demand across AI, automotive, and defense end markets.
Risks flagged
CFO retirement introduces key-person risk; but orderly transition and advisory role mitigate near-term disruption.
“CFO retiring due to family illness; will serve as advisor; search initiated.”
12 May 202610-QRevenue from customers outside the United States 58.5; Revenue from customers located in China 23.8; Net loss $-8Mopen
Figures in the filing · each found in the filing text
| Revenue from customers outside the United States · Q1-2026 | 58.5% | |
| Revenue from customers located in China · Q1-2026 | 23.8% | |
| Net loss · Q1-2026 | $-8M | |
| Accumulated deficit · Q1-2026 | $-180M | |
| Variable royalty revenue as percentage of total revenue · Q1-2026 | 11.0% |
Risks flagged
Export Control Risk
“We expect our revenue from China to decrease due to the applicable U.S. government trade restrictions.” · word for word
Tariff Risk
“Changes in diplomatic and trade relationships and uncertainties around the current U.S. administration's policies, including tariffs and reciprocal tariffs, create a highly unpredictable and volatile business environment, a potential increased likelihood of recession, potential slowdown in capital markets, and potential impacts to the valuation of the U.S. d” · word for word
Profitability Risk
“We incurred a net loss of $8.0 million and $8.1 million for the three months ended March 31, 2026 and 2025, respectively. As of March 31, 2026, we had an accumulated deficit of $179.6 million.” · word for word
Customer Concentration Risk
“A significant amount of our revenue is derived from a limited number of customers.” · word for word
21 Apr 2026DEF 14AProxy statement for 2026 annual meeting, including election of directors and ratification of auditor.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $71M | |
| SoCs shipped by customers · FY2025 | 4,000,000,000 | |
| CEO beneficial ownership · 2026-04-09 | 20.0% | |
| Performance goal achievement · FY2025 | 109.5% |
Risks flagged
Macroeconomic and geopolitical uncertainty
“we believe we are well positioned to take advantage of market opportunities while navigating ongoing macroeconomic and geopolitical uncertainty.” · word for word
12 Feb 202610-KNet loss $-35M (+3% y/y); Accumulated deficit $-172M; R&D spend $50Mopen
Figures in the filing · each found in the filing text
| Net loss · FY2025 | $-35M | +3% y/y |
| Accumulated deficit · 2025-12-31 | $-172M | |
| R&D spend · FY2025 | $50M | |
| China revenue percentage · China · FY2025 | 24.5% | |
| International revenue percentage · International · FY2025 | 60.3% | |
| Employees · 2025-12-31 | 299 | |
| Patents · 2025-12-31 | 115 |
Risks flagged
China revenue decline due to trade restrictions
“We expect our revenue from China to decrease due to the applicable U.S. government trade restrictions.” · word for word
Persistent net losses and accumulated deficit
“We incurred a net loss of $34.7 million and $33.6 million for the years ended December 31, 2025 and 2024, respectively.” · word for word
Customer concentration
“A significant amount of our revenue is derived from a limited number of customers.” · word for word
12 Feb 20268-K · 2.02Annual Contract Value plus royalties $84M (+28% y/y); Revenue $20M (+30% y/y); Remaining Performance Obligation $117M (+32% y/y); Guidance: Q1 ACV+royalties guidance $85-89M; FY2026 $100-104Mearningsopen
Figures in the filing · each found in the filing text
| Annual Contract Value plus royalties · Q4-2025 | $84M | +28% y/y |
| Revenue · Q4-2025 | $20M | +30% y/y |
| Remaining Performance Obligation · Q4-2025 | $117M | +32% y/y |
| Revenue (Full Year) · FY2025 | $71M | +22% y/y |
| Variable royalties (Full Year) · FY2025 | $7M | +50% y/y |
Guidance
Q1 ACV+royalties guidance $85-89M; FY2026 $100-104M
Raised ACV+royalties guidance for Q1 and full year FY2026; record backlog and strong demand from AI, automotive, and cybersecurity end markets.
11 Dec 20258-K · 1.01Total consideration $45M; Cash consideration $14M; Stock consideration $20Mopen
Figures in the filing · each found in the filing text
| Total consideration · point_in_time | $45M | |
| Cash consideration · point_in_time | $14M | |
| Stock consideration · point_in_time | $20M | |
| Earnout consideration · FY2026 | $12M |
Risks flagged
Integration risk and earnout dependency on Cycuity bookings.
“contingent upon Cycuity achieving certain specified bookings milestones for the 2026 calendar year” · word for word
4 Nov 20258-K · 2.02Annual Contract Value plus royalties $75M (+24% y/y); Remaining Performance Obligations $105M (+34% y/y); Revenue $17M (+18% y/y); Guidance: FY2025 revenue guidance raised to $68.8-$69.2Mearningsopen
Figures in the filing · each found in the filing text
| Annual Contract Value plus royalties · Q3-2025 | $75M | +24% y/y |
| Remaining Performance Obligations · Q3-2025 | $105M | +34% y/y |
| Revenue · Q3-2025 | $17M | +18% y/y |
| Non-GAAP operating loss · Q3-2025 | $4M | |
| Non-GAAP net loss per share · Q3-2025 | $0.09 | |
| Non-GAAP free cash flow · Q3-2025 | $3M | |
| Revenue guidance (FY2025) · FY2025 | $69M |
Guidance
FY2025 revenue guidance raised to $68.8-$69.2M
Raised FY2025 revenue guidance, record ACV+royalties and RPO, strong demand in AI and autonomous driving.
Risks flagged
Operating losses persist, though narrowing on a non-GAAP basis
“Operating loss of $8.7 million, compared to an operating loss of $7.9 million in the third quarter of 2024” · word for word
4 Nov 202510-QNet loss $-9M; Accumulated deficit $163M; Revenue from China 24.4open
Figures in the filing · each found in the filing text
| Net loss · Q3-2025 | $-9M | |
| Accumulated deficit · 2025-09-30 | $163M | |
| Revenue from China · 9M-2025 | 24.4% | |
| Variable royalty revenue · 9M-2025 | 8.1% |
Risks flagged
China revenue decline due to trade restrictions
“We expect our revenue from China to decrease due to the applicable U.S. government trade restrictions.” · word for word
History of net losses and accumulated deficit
“We incurred a net loss of $9.0 million and $7.7 million for the three months ended September 30, 2025 and 2024, respectively, and $26.2 million and $25.4 million for the nine months ended September 30, 2025 and 2024. As of September 30, 2025, we had an accumulated deficit of $163.1 million.” · word for word
Dependence on a small number of customers
“A significant amount of our revenue is derived from a limited number of customers.” · word for word
Arteris, Inc. — questions
- What did Arteris, Inc. file recently?
- 11 SEC filings in the last 12 months. Latest: 8-K on 2026-08-06 — Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)
Every figure on this page comes from Arteris, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.